lack of
regulatory control
regulatory support
long list
long game
long as
high comorbidity
lack of replication
regulatory processes
regulatory and
long clinical
regulatory authorities
lack of association
inconsistent genotype-phenotype
regulatory decision
high socio-economic costs
high dependence
lack studies
inconsistent therapeutic
inconsistent evidence
long record
long follow-up
high frequency
inconsistent in
inconsistent results
folate pharmacogenetics
long response-time
regulatory decision-making
small-sample clinical
lack key
inconsistent.
regulatory issues
lack of validation
regulatory policies
lack of studies
long migration
inconsistent across
high sensitivity
long time
inconsistent association
lack sensitivity
regulatory relationships
regulatory affairs
lack of sector
regulatory network
lack of fda
inconsistent conclusions
lack of methodology
long and
regulatory factors
regulatory light
long half-life
high personal
long 7-repeat
inconsistent and
lack in
regulatory pharmacogenetics
regulatory element
long latency
lack sufficient
long allele
inconsistent,
long road
regulatory molecular
regulatory genome
regulatory agencies
long overdue
lack of standardization
long way
regulatory hurdles
incremental costs
high performance
long periods
lack an
inconsistent clinical
regulatory experience
lack of pharmacogenetics studies
lack replication
regulatory scheme
high volume
regulatory consideration
long pcrs
lack resources
long it
long history
regulatory parties
regulatory agency
inconsistent influence
regulatory effect
lack long-term
regulatory nuclear